News

LSU Health New Orleans Announces Non-additive, Non-Toxic Painkiller

LSU Health New Orleans announces the discovery and clinical development of a new non-opioid therapeutic…

Sep 19, 2024
FDA approves First Nasal Spray for Treatment of Anaphylaxis (neffy) epinephrine nasal spray

Neffy (epinephrine 2 mg/dose) is a nasal spray which may be given to treat a…

Aug 26, 2024
Carlisle Medical Will Be Exhibiting at the 2024 MWCEA Conference

Carlisle Medical Will Be exhibiting at the 2024 MWCEA Conference on April 10-12, 2024, at…

Feb 29, 2024
Carlisle Medical Will Be Exhibiting at the SCPRIMA 2024 Annual Conference

Carlisle Medical Will Be Exhibiting at the 2024 SCPRIMA Annual Conference on March 3 –…

Feb 15, 2024
The Carlisle Drug Reference Guide

As we enter 2024 we would like to remind you of the Carlisle Drug Reference…

Dec 11, 2023
Opvee (Nalmefene) Will Be Released in the Fourth Quarter of 2023

 Opvee (Nalmefene) Will Be Released in the Fourth Quarter of 2023 Opvee is indicated for…

Jun 21, 2023
Release of Zavzpret In Late July 2023

Release of Zavzpret In Late July 2023 Zavzpret is indicated for the acute treatment of…

Jun 19, 2023
The Approval of Over-the-Counter Narcan Nasal Spray

The approval of over-the counter Narcan nasal spray  The U.S. Food and Drug Administration approved…

Apr 14, 2023
Generic Latuda (Lurasidone Hydrochloride) Is Now Available

The generic formulation of Latuda (Lurasidone Hydrochloride) has been approved by the FDA. Lurasidone Hydrochloride…

Mar 03, 2023
Generic Release Of Trokendi XR Is Now Available

Launch of generic Trokendi XR (Topiramate capsule, extended release)  Topiramate extended-release capsules are indicated as…

Feb 01, 2023